Works matching AU Tortorici, Michael

Results: 30

Long-term evaluation of analytical methods used in sirolimus therapeutic drug monitoring.

Published in:

Clinical Transplantation, 2014, v. 28, n. 2, p. 243, doi. 10.1111/ctr.12305

By:

Holt, David W.;
Mandelbrot, Didier A.;
Tortorici, Michael A.;
Korth‐Bradley, Joan M.;
Sierka, Debra;
Levy, Daniel I.;
See Tai, Sandi;
Horowitz, Gary L.

Publication type:

Article

Pharmacokinetic Analysis of Weekly Versus Biweekly IgPro20 Dosing in Patients With Primary Immunodeficiency.

Published in:

Clinical Pharmacology in Drug Development, 2020, v. 9, n. 6, p. 664, doi. 10.1002/cpdd.753

By:

Rojavin, Mikhail A.;
Chapdelaine, Hugo;
Tortorici, Michael A.;
Praus, Michaela;
Baheti, Gautam;
Zhang, Ying;
Hofmann, Jutta;
Labrosse, Roxane;
Dicaire, Renée;
Haddad, Elie

Publication type:

Article

Pharmacokinetics and Safety of CSL112 (Apolipoprotein A‐I [Human]) in Adults With Moderate Renal Impairment and Normal Renal Function.

Published in:

Clinical Pharmacology in Drug Development, 2019, v. 8, n. 5, p. 628, doi. 10.1002/cpdd.618

By:

Tortorici, Michael A.;
Duffy, Danielle;
Evans, Rebecca;
Feaster, John;
Gille, Andreas;
Mant, Timothy G. K.;
Wright, Samuel D.;
D'Andrea, Denise

Publication type:

Article

Current and Next Steps Toward Prediction of Human Dose for Gene Therapy Using Translational Dose‐Response Studies.

Published in:

Clinical Pharmacology & Therapeutics, 2021, v. 110, n. 5, p. 1176, doi. 10.1002/cpt.2374

By:

Aksenov, Sergey;
Roberts, John C.;
Mugundu, Ganesh;
Mueller, Karen Thudium;
Bhattacharya, Indranil;
Tortorici, Michael A.

Publication type:

Article

The evaluation of potential pharmacokinetic interaction between sirolimus and tacrolimus in healthy volunteers.

Published in:

European Journal of Clinical Pharmacology, 2013, v. 69, n. 4, p. 835, doi. 10.1007/s00228-012-1407-2

By:

Tortorici, Michael;
Parks, Virginia;
Matschke, Kyle;
Korth-Bradley, Joan;
Patat, Alain

Publication type:

Article

Meta-analysis of contribution of genetic polymorphisms in drug-metabolizing enzymes or transporters to axitinib pharmacokinetics.

Published in:

European Journal of Clinical Pharmacology, 2012, v. 68, n. 5, p. 645, doi. 10.1007/s00228-011-1171-8

By:

Brennan, Meghan;
Williams, J.;
Chen, Ying;
Tortorici, Michael;
Pithavala, Yazdi;
Liu, Yingxue

Publication type:

Article

Pharmacokinetic properties of Privigen<sup>®</sup> in Japanese patients with primary immunodeficiency.

Published in:

Immunological Medicine, 2019, v. 42, n. 4, p. 162, doi. 10.1080/25785826.2019.1700085

By:

Morio, Tomohiro;
Baheti, Gautam;
Tortorici, Michael A.;
Hofmann, Jutta;
Rojavin, Mikhail A.

Publication type:

Article

A pharmacodynamically guided dose selection of PF-00337210 in a phase I study in patients with advanced solid tumors.

Published in:

2016

By:

Bruce, Justine;
LoRusso, Patricia;
Goncalves, Priscila;
Heath, Elisabeth;
Sadowski, Elizabeth;
Shalinsky, David;
Zhang, Yanwei;
Traynor, Anne;
Breazna, Aurora;
Ricart, Alejandro;
Tortorici, Michael;
Liu, Glenn;
Bruce, Justine Yang;
LoRusso, Patricia M;
Goncalves, Priscila H;
Heath, Elisabeth I;
Shalinsky, David R;
Traynor, Anne M;
Ricart, Alejandro D

Publication type:

journal article

Effect of axitinib on the QT interval in healthy volunteers.

Published in:

Cancer Chemotherapy & Pharmacology, 2015, v. 75, n. 3, p. 619, doi. 10.1007/s00280-015-2677-z

By:

Ruiz-Garcia, Ana;
Houk, Brett;
Pithavala, Yazdi;
Toh, Melvin;
Sarapa, Nenad;
Tortorici, Michael

Publication type:

Article

Pharmacokinetics of single-agent axitinib across multiple solid tumor types.

Published in:

Cancer Chemotherapy & Pharmacology, 2014, v. 74, n. 6, p. 1279, doi. 10.1007/s00280-014-2606-6

By:

Tortorici, Michael;
Cohen, Ezra;
Pithavala, Yazdi;
Garrett, May;
Ruiz-Garcia, Ana;
Kim, Sinil;
Fruehauf, John

Publication type:

Article

Evaluation of the effect of food on the pharmacokinetics of axitinib in healthy volunteers.

Published in:

Cancer Chemotherapy & Pharmacology, 2012, v. 70, n. 1, p. 103, doi. 10.1007/s00280-012-1888-9

By:

Pithavala, Yazdi;
Chen, Ying;
Toh, Melvin;
Selaru, Paulina;
LaBadie, Robert;
Garrett, May;
Hee, Brian;
Mount, Janessa;
Ni, Grace;
Klamerus, Karen;
Tortorici, Michael

Publication type:

Article

Pharmacometric analyses to characterize the effect of CSL112 on apolipoprotein A‐I and cholesterol efflux capacity in acute myocardial infarction patients.

Published in:

British Journal of Clinical Pharmacology, 2021, v. 87, n. 6, p. 2558, doi. 10.1111/bcp.14666

By:

Zheng, Bo;
Duffy, Danielle;
Tricoci, Pierluigi;
Kastrissios, Helen;
Pfister, Marc;
Wright, Samuel D.;
Gille, Andreas;
Tortorici, Michael A.

Publication type:

Article

Quantitative disease progression model of α-1 proteinase inhibitor therapy on computed tomography lung density in patients with α-1 antitrypsin deficiency.

Published in:

British Journal of Clinical Pharmacology, 2017, v. 83, n. 11, p. 2386, doi. 10.1111/bcp.13358

By:

Tortorici, Michael A.;
Rogers, James A.;
Vit, Oliver;
Bexon, Martin;
Sandhaus, Robert A.;
Burdon, Jonathan;
Chorostowska‐Wynimko, Joanna;
Thompson, Philip;
Stocks, James;
McElvaney, Noel G.;
Chapman, Kenneth R.;
Edelman, Jonathan M.

Publication type:

Article

Clinical Pharmacology of Axitinib.

Published in:

Clinical Pharmacokinetics, 2013, v. 52, n. 9, p. 713, doi. 10.1007/s40262-013-0068-3

By:

Chen, Ying;
Tortorici, Michael;
Garrett, May;
Hee, Brian;
Klamerus, Karen;
Pithavala, Yazdi

Publication type:

Article

Axitinib plasma pharmacokinetics and ethnic differences.

Published in:

Investigational New Drugs, 2015, v. 33, n. 2, p. 521, doi. 10.1007/s10637-015-0214-x

By:

Chen, Ying;
Suzuki, Akiyuki;
Tortorici, Michael;
Garrett, May;
LaBadie, Robert;
Umeyama, Yoshiko;
Pithavala, Yazdi

Publication type:

Article

Influence of mild and moderate hepatic impairment on axitinib pharmacokinetics.

Published in:

Investigational New Drugs, 2011, v. 29, n. 6, p. 1370, doi. 10.1007/s10637-010-9477-4

By:

Tortorici, Michael;
Toh, Melvin;
Rahavendran, S.;
LaBadie, Robert;
Alvey, Christine;
Marbury, Thomas;
Fuentes, Ernesto;
Green, Matthew;
Ni, Grace;
Hee, Brian;
Pithavala, Yazdi

Publication type:

Article

First‐in‐human study evaluating safety, pharmacokinetics, and pharmacodynamics of lorundrostat, a novel and highly selective aldosterone synthase inhibitor.

Published in:

CTS: Clinical & Translational Science, 2024, v. 17, n. 8, p. 1, doi. 10.1111/cts.70000

By:

Shimizu, Hidetoshi;
Tortorici, Michael A.;
Ohta, Yoshiyasu;
Ogawa, Kei;
Rahman, Sheikh Mohammed Ashfaq;
Fujii, Aya;
Hiraga, Yuki;
Kawai, Mizue;
Sugimoto‐Kawabata, Kanami;
van Iersel, Mattheus;
van Lier, Jan Jaap;
Djedjos, Stephen;
Slingsby, B. T.;
Rodman, David M.

Publication type:

Article

Effect of CSL112 (apolipoprotein A‐I [human]) on cholesterol efflux capacity in Japanese subjects: Findings from a phase I study and a cross‐study comparison.

Published in:

CTS: Clinical & Translational Science, 2022, v. 15, n. 10, p. 2331, doi. 10.1111/cts.13361

By:

Zheng, Bo;
Goto, Shinya;
Clementi, Regina;
Feaster, John;
Duffy, Danielle;
Dalitz, Penelope;
Airey, Jolanta;
Korjian, Serge;
Tortorici, Michael A.;
Roberts, John;
Gibson, C. Michael

Publication type:

Article

Pharmacokinetic/pharmacodynamic modeling for dose selection for the first‐in‐human trial of the activated Factor XII inhibitor garadacimab (CSL312).

Published in:

CTS: Clinical & Translational Science, 2022, v. 15, n. 3, p. 709, doi. 10.1111/cts.13192

By:

Pawaskar, Dipti;
Chen, Xi;
Glassman, Fiona;
May, Frauke;
Roberts, Anthony;
Biondo, Mark;
McKenzie, Andrew;
Nolte, Marc W.;
Jusko, William J.;
Tortorici, Michael

Publication type:

Article

Long-Term Efficacy and Safety of Hizentra® in Patients with Primary Immunodeficiency in Japan, Europe, and the United States: a Review of 7 Phase 3 Trials.

Published in:

Journal of Clinical Immunology, 2018, v. 38, n. 8, p. 864, doi. 10.1007/s10875-018-0560-5

By:

Jolles, Stephen;
Rojavin, Mikhail A.;
Lawo, John-Philip;
Nelson, Robert;
Wasserman, Richard L.;
Borte, Michael;
Tortorici, Michael A.;
Imai, Kohsuke;
Kanegane, Hirokazu

Publication type:

Article

Hazards of colchicine.

Published in:

2005

By:

Tortorici, Michael A.;
Skledar, Sue;
Barnes, Barbara;
Wasko, Mary Chester M.

Publication type:

Letter

Promoting the safe use of intravenous colchicine.

Published in:

American Journal of Health-System Pharmacy, 2004, v. 61, n. 23, p. 2496, doi. 10.1093/ajhp/61.23.2496

By:

Tortorici, Michael A.;
Skiedar, Sue;
Barnes, Barbara;
Wasko, Mary Chester M.

Publication type:

Article

Kidney function assessment and its role in drug development, review and utilization.

Published in:

Expert Review of Clinical Pharmacology, 2014, v. 7, n. 4, p. 523, doi. 10.1586/17512433.2014.922865

By:

Tortorici, Michael A;
Nolin, Thomas D

Publication type:

Article

Pharmacometric analysis linking immunoglobulin exposure to clinical efficacy outcomes in chronic inflammatory demyelinating polyneuropathy.

Published in:

CPT: Pharmacometrics & Systems Pharmacology, 2021, v. 10, n. 8, p. 839, doi. 10.1002/psp4.12647

By:

Tortorici, Michael A.;
Yuraszeck, Theresa;
Cornblath, David;
Bril, Vera;
Hartung, Hans‐Peter;
Sobue, Gen;
Lewis, Richard A.;
Merkies, Ingemar S. J.;
Lawo, John‐Philip;
Praus, Michaela;
Durn, Billie L.;
Mielke, Orell;
Ma, Xuewen;
Jauslin, Petra;
Pfister, Marc;
van Schaik, Ivo N.

Publication type:

Article

Exposure‐Response Model of Subcutaneous C1‐Inhibitor Concentrate to Estimate the Risk of Attacks in Patients With Hereditary Angioedema.

Published in:

CPT: Pharmacometrics & Systems Pharmacology, 2018, v. 7, n. 3, p. 158, doi. 10.1002/psp4.12271

By:

Zhang, Ying;
Tortorici, Michael A.;
Pawaskar, Dipti;
Pragst, Ingo;
Machnig, Thomas;
Hutmacher, Matthew;
Zuraw, Bruce;
Cicardi, Marco;
Craig, Timothy;
Longhurst, Hilary;
Sidhu, Jagdev

Publication type:

Article

Population pharmacokinetics of subcutaneous C1‐inhibitor for prevention of attacks in patients with hereditary angioedema.

Published in:

Clinical & Experimental Allergy, 2018, v. 48, n. 10, p. 1325, doi. 10.1111/cea.13220

By:

Pawaskar, Dipti;
Tortorici, Michael A.;
Zuraw, Bruce;
Craig, Timothy;
Cicardi, Marco;
Longhurst, Hilary;
Li, H. Henry;
Lumry, William R.;
Martinez‐Saguer, Inmaculada;
Jacobs, Joshua;
Bernstein, Jonathan A.;
Riedl, Marc A.;
Katelaris, Constance H.;
Keith, Paul K.;
Feussner, Annette;
Sidhu, Jagdev

Publication type:

Article

Moderate Renal Impairment Does Not Impact the Ability of CSL112 (Apolipoprotein A‐I [Human]) to Enhance Cholesterol Efflux Capacity.

Published in:

Journal of Clinical Pharmacology, 2019, v. 59, n. 3, p. 427, doi. 10.1002/jcph.1337

By:

Gille, Andreas;
Duffy, Danielle;
Tortorici, Michael A.;
Wright, Samuel D.;
Deckelbaum, Lawrence I.;
D'Andrea, Denise M.

Publication type:

Article

Dosage Adjustments Related to Young or Old Age and Organ Impairment.

Published in:

Journal of Clinical Pharmacology, 2016, v. 56, n. 12, p. 1461, doi. 10.1002/jcph.816

By:

Burris, James F.;
Tortorici, Michael A.;
Mandic, Maja;
Neely, Michael;
Reed, Michael D.

Publication type:

Article

Emerging Areas of Research in the Assessment of Pharmacokinetics in Patients With Chronic Kidney Disease.

Published in:

Journal of Clinical Pharmacology, 2015, v. 55, n. 3, p. 241, doi. 10.1002/jcph.444

By:

Tortorici, Michael A.;
Cutler, David L.;
Hazra, Anasuya;
Nolin, Thomas D.;
Rowland‐Yeo, Karen;
Venkatakrishnan, Karthik

Publication type:

Article

Design, Conduct, Analysis, and Interpretation of Clinical Studies in Patients With Impaired Kidney Function.

Published in:

Journal of Clinical Pharmacology, 2012, v. 52, p. 109S, doi. 10.1177/0091270011416364

By:

Tortorici, Michael A.;
Cutler, David;
Zhang, Lei;
Pfister, Marc

Publication type:

Article